Paolo Farneti/LinkedIn
Aug 11, 2025, 01:43
Delphi Consensus: A Safe Guide to Use of Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-related Epistaxis
JAMA Otolaryngology – Head & Neck Surgery shared an insightful post on X:
”A Delphi consensus among six international experts established 30 statements to guide the safe and effective use of sclerotherapy for hereditary hemorrhagic telangiectasia (HHT)-related epistaxis.”
Read the full article here.
Article: Consensus on Sclerotherapy for Patients With Hereditary Hemorrhagic Telangiectasia–Related Epistaxis
Authors: Paolo Farneti, Sol Marcos-Salazar, Claudia Crocione,Holly Boyer, Roberto Puxeddu, Alan B. Whitehouse, Jay F. Piccirillo
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team